| PERIOD ENDING | 2-Aug-09 | 3-May-09 | 1-Feb-09 | 2-Nov-08 | | Total Revenue | 82,730 | 93,420 | 91,768 | 94,338 | | Cost of Revenue | 71,258 | 76,968 | 80,081 | 87,143 | | | Gross Profit | 11,472 | 16,452 | 11,687 | 7,195 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,074 | 6,324 | 6,927 | 6,055 | | Non Recurring | 1,456 | 2,357 | 1,196 | 345 | | Others | 1,999 | 1,993 | 2,100 | 2,107 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,943 | 5,778 | 1,464 | (1,312) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (486) | 14 | 2,788 | (856) | | Earnings Before Interest And Taxes | 2,243 | 5,893 | 4,151 | (2,503) | | Interest Expense | 2,312 | 3,817 | 3,338 | 2,978 | | Income Before Tax | (69) | 2,076 | 813 | (5,481) | | Income Tax Expense | 88 | 208 | 1,116 | 404 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (157) | 1,868 | (303) | (5,885) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (157) | 1,868 | (303) | (5,885) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($157) | $1,868 | ($303) | ($5,885) |
|
0.31% Nasdaq 
0.05%
Income Statement
